BCI, an inhibitor of the DUSP1 and DUSP6 dual specificity phosphatases, enhances P2X7 receptor expression in neuroblastoma cells
P2X7 receptor (P2RX7) is expressed strongly by most human cancers, including neuroblastoma, where high levels of P2RX7 are correlated with a poor prognosis for patients. Tonic activation of P2X7 receptor favors cell metabolism and angiogenesis, thereby promoting cancer cell proliferation, immunosupp...
Main Authors: | María Benito-León, Juan Carlos Gil-Redondo, Raquel Perez-Sen, Esmerilda G. Delicado, Felipe Ortega, Rosa Gomez-Villafuertes |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-12-01
|
Series: | Frontiers in Cell and Developmental Biology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcell.2022.1049566/full |
Similar Items
-
Physiopathological Role of the Vesicular Nucleotide Transporter (VNUT) in the Central Nervous System: Relevance of the Vesicular Nucleotide Release as a Potential Therapeutic Target
by: María T. Miras-Portugal, et al.
Published: (2019-05-01) -
Nucleotide-Induced Nanoscale Changes in the Mechanical Properties of Rat Cerebellar Astrocytes: Selective Stimulation and Blocking of the Purinergic Receptor P2X7
by: Juan Carlos Gil-Redondo, et al.
Published: (2022-10-01) -
Nucleotides-Induced Changes in the Mechanical Properties of Living Endothelial Cells and Astrocytes, Analyzed by Atomic Force Microscopy
by: Juan Carlos Gil-Redondo, et al.
Published: (2021-01-01) -
Dissecting the Purinergic Signaling Puzzle
by: Raquel Pérez-Sen, et al.
Published: (2021-08-01) -
DUSP12 regulates the tumorigenesis and prognosis of hepatocellular carcinoma
by: Gaoda Ju, et al.
Published: (2021-08-01)